CTOs on the Move

UP Health System – Marquette

www.mgh.org

 
Marquette General Health System is a Marquette, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.mgh.org
  • 580 W. College Ave.
    Marquette, MI USA 49855
  • Phone: 906.228.9440

Executives

Name Title Contact Details

Similar Companies

AMD LASERS

AMD LASERS is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Adjuvant Group

The Adjuvant Group is a Scotch Plains, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ivoclar Vivadent

Ivoclar Vivadent is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Ivoclar Vivadent is based in Buffalo, NY. You can find more information on Ivoclar Vivadent at www.ivoclarvivadent.us

LMA North America

LMA North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioatla

BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.